Lin L, Gehlert D R, York D A, Bray G A
Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70808-4124, USA.
Obes Res. 1993 May;1(3):186-92. doi: 10.1002/j.1550-8528.1993.tb00610.x.
We have investigated the possibility that enterostatin may inhibit the intake of dietary fat by inhibiting either galanin or NPY-induced feeding pathways. Rats, adapted to either high fat (HF) or low fat-high carbohydrate (HC) diets and fitted with third ventricular cannulas were used to study the effects of intracerebroventricular (i.c.v.) enterostatin on i.c.v. NPY and galanin induced feeding responses in satiated rats. An equimolar dose of enterostatin (0.1 nmoles) inhibited, while a tenfold excess of enterostatin abolished the feeding response to galanin in rats adapted to a HF diet. The galanin stimulation of food intake was reduced in rats adapted to the HC diet and this response was less sensitive to inhibition by enterostatin. Enterostatin had no inhibitory effects on NPY-induced feeding in rats adapted to the HC diet and only a small inhibitory effect, at tenfold molar excess, in rats adapted to the HF diet. The ability of enterostatin to bind to galanin or NPY Y-1 receptors was investigated in ligand binding studies. Enterostatin failed to displace 125I-galanin or 125I-PYY from specific binding sites in rat forebrain homogenates or SK-N-MC cells respectively. The data provide support for the hypothesis that enterostatin specifically inhibits a galanin-responsive fat intake system, but indicate that this effect is not modulated by direct interaction with either galanin or NPY-Y1 receptors.
我们研究了肠抑胃素可能通过抑制甘丙肽或神经肽Y(NPY)诱导的进食途径来抑制膳食脂肪摄入的可能性。将适应高脂肪(HF)或低脂高碳水化合物(HC)饮食并植入第三脑室插管的大鼠用于研究脑室内(i.c.v.)注射肠抑胃素对饱足大鼠脑室内注射NPY和甘丙肽诱导的进食反应的影响。等摩尔剂量的肠抑胃素(0.1纳摩尔)具有抑制作用,而十倍过量的肠抑胃素则消除了适应HF饮食的大鼠对甘丙肽的进食反应。在适应HC饮食的大鼠中,甘丙肽对食物摄入的刺激作用减弱,并且这种反应对肠抑胃素抑制的敏感性较低。肠抑胃素对适应HC饮食的大鼠中NPY诱导的进食没有抑制作用,而在适应HF饮食的大鼠中,仅在十倍摩尔过量时才有较小的抑制作用。在配体结合研究中,研究了肠抑胃素与甘丙肽或NPY Y-1受体结合的能力。肠抑胃素分别未能从大鼠前脑匀浆或SK-N-MC细胞中的特异性结合位点置换125I-甘丙肽或125I-胰酪肽。这些数据支持了肠抑胃素特异性抑制甘丙肽反应性脂肪摄入系统的假说,但表明这种作用不是通过与甘丙肽或NPY-Y1受体的直接相互作用来调节的。